Jf. Fortin et al., HOST-DERIVED ICAM-1 GLYCOPROTEINS INCORPORATED ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE BIOLOGICALLY-ACTIVE AND ENHANCE VIRAL INFECTIVITY, Journal of virology, 71(5), 1997, pp. 3588-3596
Human immunodeficiency virus type 1 (HIV-1) acquires several host cell
membrane proteins when it buds from infected cells, To study the effe
ct of virally incorporated host-derived ICAM-1 glycoproteins on the bi
ology of HIV-1, we have developed a transient expression system that h
as enabled us to produce virus particles differing only in the absence
or the presence of virion-bound ICAM-1. By using a single-round infec
tion assay based on an ICAM-1-negative target T-cell line stably trans
fected with an HIV-1 long terminal repeat driven luciferase gene const
ruct, we have been able to demonstrate that the acquisition of host-de
rived ICAM-1 by HIV-1 has functional significance, since it leads to a
pronounced increase in viral infectivity (4.6- to 9.8-fold) in an ICA
M-1/LFA-1-dependent fashion, as shown by blocking with anti-ICAM-1 and
-LFA-1 antibodies. The same potentiating effect on viral infectivity
was also observed with monocytoid cells, Studies of the kinetics of in
fection revealed that the positive effect mediated by virally embedded
host cell membrane ICAM-1 is due to an increase in the efficiency of
early steps in the viral life cycle, These results provide new insight
s into how incorporation of host proteins can modulate the biological
properties of HIV-1, Our findings have direct clinical relevance, cons
idering that ICAM-1 is expressed on the surface of virus-infected cell
s and, more importantly, that host-derived ICAM-1 has been shown to be
acquired by clinical HIV-1 isolates grown on primary mononuclear cell
s. These data justify a more complete analysis of the other putative r
ole(s) that virally incorporated ICAM-1 may play in the life cycle of
HIV-1, for example, at the level of neutralization sensitivity.